Med-IQ Logo
Get CME/CE
Journal Supplement Journal Supplement

Diagnosing and Managing Schizophrenia: Practical Strategies for the Federal Healthcare Professional


Time to Complete:
60 Minutes
Released:
5/26/11
Expires:
5/25/12

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)

Journal SupplementJournal Supplement
Time to Complete:
60 Minutes

Released:
5/26/11

Expires:
5/25/12

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)
Share on:
Journal SupplementJournal Supplement

Share on:


Time to Complete:
60 Minutes
Released:
5/26/11
Expires:
5/25/12


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 California Board of Registered Nursing (CBRN)
1.0 Accreditation Council for Pharmacy Education (ACPE)


Overview: This activity addresses important issues in the identification, diagnosis, and management of schizophrenia in patients within the federal healthcare system, which includes active-duty servicemembers, Veterans, and others. It is designed to increase the awareness of schizophrenia as a possible diagnosis among other common conditions in this patient population, assist with the development of treatment plans based on current guideline recommendations, and guide the modification of treatment regimens based on patient response, adverse effects, adherence concerns, and other treatment challenges.

Faculty

Mark Olfson, MD, MPH
Professor of Clinical Psychiatry
College of Physicians and Surgeons of Columbia University
Research Psychiatrist
New York State Psychiatric Institute
New York, NY

William V. Bobo, MD, MPH
Assistant Professor of Psychiatry
Vanderbilt University School of Medicine
Nashville, TN

Robert A. Rosenheck, MD
Professor of Psychiatry and Public Health
Director, Division of Mental Health Services and Outcomes Research
Department of Psychiatry
Yale School of Medicine
New Haven, CT


Disclosure Policy

The College of Physicians and Surgeons and Med-IQ require any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. The College of Physicians and Surgeons and Med-IQ have policies in place that will identify and resolve COIs prior to this educational activity. The College of Physicians and Surgeons and Med-IQ also require faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Mark Olfson, MD, MPH has indicated no real or apparent conflicts.
 
William V. Bobo, MD has indicated no real or apparent conflicts.
 
Robert A. Rosenheck, MD
Consulting fees/advisory boards: Otsuka America Pharmaceutical, Inc.
Contracted research: Janssen

The writer (Katherine Kahn), activity planners (Rachel Karcher and Lisa Rinehart), and other employees of Med-IQ and the College of Physicians and Surgeons have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.